Specialized training in antibody conjugates is essential for hospital pharmacists to acquire the specific skills and knowledge needed to handle these drugs appropriately and efficiently, optimizing therapeutic outcomes and minimizing adverse effects.

The integration of pharmacogenetics and pharmacogenomics into clinical practice addresses a priority need in the field of personalized treatments, an approach that has proven effective in improving health outcomes and optimizing the safety and efficacy of medications.

Chronic obstructive pulmonary disease affects more than 10% of the population over 40 years of age, asthma more than 5%, and rhinitis with nasal polyposis 4%. However, there are other respiratory pathologies that, although less prevalent, have a high impact and high mortality for the patient, such as pulmonary hypertension, diffuse lung diseases, cystic fibrosis, and certain infections, among others.
This course allows the hospital pharmacist to have a global vision of the pathophysiology, diagnosis, general management and respiratory pharmacotherapy to be able to implement this knowledge and skills in their clinical practice, and thereby ensure the best care for patients.

18 sessions of 1 hour duration, spread over the 2024-2025 academic year.
Training aimed at members who wish to receive an update on Pharmacotherapy topics.
OBJECTIVES: To acquire and consolidate knowledge about pharmacotherapy in the following areas: Oncohematology, Pediatrics, Nutrition, infectious diseases, critical patients, Cardiology, Psychiatry, Geriatrics and general pharmacotherapy.

The SCIENTIFIC READING WORKSHOPS program: THE ART OF CRITICAL REVIEW, has been designed to generate confidence in the critical evaluation process by applying and evaluating the available evidence from scientific research.
Due to the enormous amount of scientific data that is published, especially on medications, it can be difficult to interpret all aspects of the studies with confidence, so critical reading of this evidence will improve decision-making about medications that will result in the results in patients.
Being able to critically evaluate published research is a key skill for anyone involved in treatment use and decision-making in a multidisciplinary context.

The Spanish Society of Hospital Pharmacists (SEFH), with the sponsorship of GSK, has created FHarmateca, a repository of information and knowledge about hospital pharmacy. The goal behind this initiative was to contribute to the training of pharmacists who are in the process of preparing themselves to take a competitive exam obtain a staff position in a hospital. Some autonomous regions lacking a clear syllabus for such exams, SEFH thought it necessary to produce a high-quality tool that can be used as a reference all over the country. This is how FHarmateca came into being as a repository of up-to-date resources for hospital pharmacists.